Parathyroidectomy After Kidney Transplantation

Recruiting N/A Interventional Study
Hyperparathyroidism Kidney Transplantation Recipients
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
85 (estimated)
Sponsor
Aarhus University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study aims to clarify whether surgical treatment of persistent hyperparathyroidism after kidney transplantation offers clinically meaningful benefits compared with a conservative treatment strategy. Kidney transplant recipients (\>6 mo after transplantation) with persistent hyperparathyroidism (elevated PTH and either hypercalcemia or hypophosphatemia) will be randomized in a 1:1 ratio to ei…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria * Age \> 18 years and legally competent and able to understand spoken and written Danish * Kidney transplantation ≥6 months prior (no upper limit of time after transplantation) * Stable kidney graft function, defined as estimated GFR ≥ 30 ml/min/1.73m3 * On minimum two separate b…
Contacts

Hanne S Jørgensen, MD, PhD

+45 51 41 35 41

hsjorgensen@clin.au.dk

CONTACT

Amal Derai, MD

+45 51 36 03 80

amader@rm.dk

CONTACT